Mediracer is preparing to enter the US market after the US Food and Drug Administration (FDA) 510(k) review for premarket notification for the Mediracer® NCS device was successfully completed (SE) and clearance to market the device in the US was granted. The...
We are proud to assist The College of Podiatry Conference with our distributor Henry Schein The College of Podiatry Conference is one of the most important events of the year for podiatrists. In 2018 over 1,350 colleagues attended and profited from the latest...
Mediracer is preparing to enter the US market after the FDA 510(k) review for premarket notification for the Mediracer® NCS system was successfully completed (SE) for our CTS Carpal Tunnel Syndrome and DPN Diabetic Peripheral Neuropathy measurement. Section 510(k) of...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.